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A B S T R A C T 
Parkinson is a neurodegenerative disease, in which tremor is the main symptom. This paper investigates 
the use of different classification methods to identify tremors experienced by Parkinsonian patients. 
Some previous research has focussed tremor analysis on external body signals (e.g., electromyography, 
accelerometer signals, etc.). Our advantage is that we have access to sub-cortical data, which facilitates 
the applicability of the obtained results into real medical devices since we are dealing with brain signals 
directly. 
Local field potentials (LFP) were recorded in the subthalamic nucleus of 7 Parkinsonian patients through 
the implanted electrodes of a deep brain stimulation (DBS) device prior to its internalization. Measured 
LFP signals were preprocessed by means of splinting, down sampling, filtering, normalization and rec-
tification. Then, feature extraction was conducted through a multi-level decomposition via a wavelet 
transform. Finally, artificial intelligence techniques were applied to feature selection, clustering of tremor 
types, and tremor detection. 
The key contribution of this paper is to present initial results which indicate, to a high degree of 
certainty, that there appear to be two distinct subgroups of patients within the group-1 of patients 
according to the Consensus Statement of the Movement Disorder Society on Tremor. Such results may 
well lead to different resultant treatments for the patients involved, depending on how their tremor has 
been classified. 
Moreover, we propose a new approach for demand driven stimulation, in which tremor detection is 
also based on the subtype of tremor the patient has. Applying this knowledge to the tremor detection 
problem, it can be concluded that the results improve when patient clustering is applied prior to detection. 
1. Introduction 
2.2. Background 
Different parts of the brain perform distinct tasks. There are 
areas devoted to control vision, memory, movement, and so 
on. The synchronization process between neurons is crucial. A 
well-coordinated synchrony between neuronal populations results 
in a decisive mechanism for neural signaling and information 
processing [1-3]. Some degree of de-synchronization however is 
the key-point to the proper functioning of neurons [4]. If neurons 
that do not work properly are in the circuits of the motor functions, 
this implies a dysfunction of the motor system, which results in 
conditions such as Parkinson's Disease (PD) [5,6]. In PD the neu-
rons start firing themselves collectively in a periodic manner due 
to the loss of dopamine secretion [7], and this is the cause of the 
resting tremor (RT), being characteristic of PD in 70% of patients 
[8-10]. 
In this study we have dealt with signals captured through sur-
gical intervention from the Subtalamic Nucleus (STN), the affected 
region in all of the analysed patients. In the following sections we 
refer to this area of the brain when we mention the collected signal. 
Moreover, the subthalamic nucleus is the preferred target for deep 
brain stimulation in patients with advanced PD [11 ]. 
Parkinson is a neurodegenerative disease, in which patients 
suffer different symptoms: resting tremor, akinesia and rigidity 
[12-14]. Some existing patients may have a very severe dis-
abling tremor, while others may not have any tremor at all. In 
this way, different studies refer to patient classification between 
tremor-dominant and non-tremor-dominant [15-18]. PD affects 
approximately 1% of the population over 55 years of age, although 
it can occur in younger subjects [19], it being the second most 
common neurodegenerative disease after Alzheimer's disease [20]. 
There is no recognized cure for PD, although there is 
treatment for the symptoms [21]. The main drug is L-dopa (L-
3,4-dihydroxyphenylalanine - levodopa), the principal metabolic 
precursor of dopamine. However, the continued use of levodopa, in 
advanced stages of the disease, entails the so-called ON-OFF effect 
in patients. The patient goes through OFF periods, in which, despite 
receiving medication, a worsening of the symptoms appears involv-
ing increased rigidity, resting tremor and bradykinesia, in a severe, 
abrupt and unpredictable way. Moreover, OFF periods alter with 
ON periods, in which the effect of medication leads to dyskinesia 
episodes (levodopa-induced dyskinesia (LID)) into patients [22,23]. 
Several previous works have studied diverse methods to detect 
and quantify PD tremors [24-26]. Most of them focus the analysis 
on external body signals such as accelerometry, electromyography 
(EMG) and/or electroencephalography (EEG) - not exploring what 
exactly is happening in the areas of interest inside the brain but 
conversely dealing with the question as a black-box problem. For-
tunately, the advantage of our experimentation is that we have 
access to sub-cortical data, which facilitates the applicability of 
the obtained results into real medical devices since we are directly 
dealing with brain signals. 
2.2.2. Deep brain stimulation 
Applying real-time medical imaging techniques, neurologists 
can recognize the optimal stimulatory target based on diagnosis for 
each patient. Electrical stimulation using electrodes implanted into 
this area then allows significant suppression of PD symptoms. This 
procedure is called deep brain stimulation (DBS) and is employed 
in patients who no longer respond properly to their medication 
[27-29]. 
The positioning and fine tuning of deep brain stimulation has 
become very accurate. Nowadays, surgeons can place electrodes in 
numerous areas of the brain, to turn-on or turn-off, stimulate or 
inhibit neuronal populations, in order to correct the malfunction 
of the regions in which the electrodes are implanted [28,30-32]. 
This technique is not only used in PD, but also in various neurolog-
ical conditions such as dystonia, epilepsy, depression, or obsessive 
compulsive disorder. 
This therapy is carried out with the use of an implanted medical 
device called a neurostimulator. Neurostimulators transmit con-
tinually high frequency electrical signals (typically 150-180 Hz) 
through one or more electrodes to various parts of the brain, stim-
ulating or suppressing abnormal neuronal activity. Regarding PD, 
this treatment restores the natural frequencies of neurons, giving 
back their asynchronous functioning [27,28,33]. 
Numerous studies conclude that DBS is as effective as ablative 
therapies [28,30,32]. Furthermore, it has the noticeable advantage 
of being a reversible therapy and the treatment can be adjusted for 
each patient - modulating the stimulation supplied by the device. 
Implantable medical devices are equipped with an integrated 
battery. The battery energizes the implant for treatment, mon-
itoring and wireless communication tasks. Once implanted, it 
can last for up to 8 years, in the case of neurostimulators [34], 
to 10 in the case of other implants such as pacemakers [35]. 
Battery consumption has a direct impact on the device lifetime. 
Once empty, it has to be replaced, which requires further surgery 
and may entail some risks [36]. Alternatively a battery can be 
recharged externally by using magnetic fields, but this option it is 
not available in most stimulators. 
Demand driven stimulation (DDS) has already been proposed 
in previous works [37,38]. The main goal of DDS is to achieve a 
more intelligent way of stimulation, such that it is only adminis-
tered when it is necessary. Under this approach, it allows for the 
brain structures, in which the electrodes are implanted, to perform 
normally during non-tremor activity instead of being stimulated all 
the time. This would be beneficial, not only in the case of Parkinson 
Disease, but also for other movement disorders such as Essen-
tial Tremor, in which the patients have a lower degree of tremor. 
Moreover, the battery would be used in a more efficient way, inde-
pendently of the way of charging it or the use of more advanced 
batteries. 
Making the neurostimulator into a smart device is also interest-
ing for other approaches. For instance, the processing and analysis 
of electrophysiological activity by the demand driven stimulation 
(DDS) device could provide clinically relevant information, such as 
duration of ON/OFF episodes, tremor frequency, etc. 
In this paper we propose a new approach for DDS, in which the 
detection of tremor is also based on the tremor subtype the patient 
suffers. 
1.2. Tremor 
Tremor is a rhythmic and involuntary movement that appears 
in one or more parts of the body [39]. There are different kinds of 
tremor, depending on: (1) the circumstances in which it appears: 
at rest, during maintenance of certain positions or while perform-
ing voluntary actions; (2) the affected body area: hands, arms and 
other body parts; and (3) the frequency at which the tremor mani-
fests itself: low (<4 Hz), medium (4-7 Hz) or high (>7 Hz) frequency 
bands. According to these three factors, tremor can be classified 
within a movement disorder pathology. 
The Consensus Statement of the Movement Disorder Society on 
Tremor [40] categorizes subtypes of tremor for this condition into 
3 distinctly separate groups: 
1. Resting tremor (RT), which is the most characteristic of PD 
tremors, occurs at a frequency band between 4 and 6 Hz [41] 
and disappears when a voluntary movement is performed. Its 
presence is a good criterion for the diagnosis of PD, since this 
sort of tremor is usually not associated with other pathologies. 
On the other hand, for the vast majority of PD patients, the res-
ting tremor emerges along with postural and/or kinetic tremors 
at the same frequency. Therefore many studies simply assume 
that it is a continuation of the resting tremor under postural, 
kinetic conditions or vice versa [42-48]. 
Postural tremor takes place when the patient suffers a tremor 
episode maintaining a position against gravity, for instance keep-
ing the arms 90° horizontally relative to the trunk. Meanwhile 
kinetic tremor occurs when the subject performs any voluntary 
movement. 
2. The second group is made up of PD patients who have episodes of 
RT together with postural/kinetic tremor episodes at higher fre-
quencies than the resting tremor, referred to as Essential Tremor 
(ET). Many research studies justify this since ET episodes can 
co-exist together with RT episodes in PD [33]. 
3. The last group includes patients who do not have resting tremor 
episodes. This subgroup of patients is only affected by kinetic 
and postural tremor episodes [49]. 
In this work, using clustering techniques, we show the existence 
of two patient subgroups within the group-1 of patients mentioned 
above according to the Consensus Statement of the Movement Dis-
order Society on Tremor. That is, patients with resting tremor in the 
band 4-6 Hz. We show that these group-1 patients can be clearly 
grouped into two further different subgroups. Unfortunately we 
do not present any particular physiological reasoning behind this 
result/conclusion, merely it is an observation from the available 
signals. Nevertheless we hope that this result can be used to con-
duct research on the existence of these sub-groups of patients and, 
above all, can be used to improve the treatment of PD. 
Apart from this, we also propose, based on this classification, a 
tremor detection system that distinguishes between the aforemen-
tioned subgroups, obtaining better results (higher accuracy) than 
if clustering is not done (i.e., a detection system that does not seg-
regate into subgroups) as shown in Section 3.2. This approach thus 
could potentially be used as an effective tool for categorizing the 
DDS required. 
2. Materials and methods 
2.1. Patient dataset 
Electrophysiology is concerned with the study of electrical activ-
ity in the body [50]. If we need to monitor the activity of a small 
population of neurons, extracellular physiology is currently the best 
technique. 
Using electrodes we can measure the activity of few cells (spik-
ing activity - SA) or instead sense the activity of a larger group of 
cells (local field potentials - LFP) [51 ]. In this study we have worked 
with LFP from the STN.The LFP is a massed neuronal signal obtained 
using a two step procedure. First we measure the extracellular elec-
trical potential with one of several intracranial microelectrodes. 
Then the signal is filtered and the resulting signal represents the 
LFP. In this procedure, the positioning of electrodes has to be very 
accurate in order to prevent a particular cell dominating the elec-
trophysiological signal. Note that LFP is a signal composed of the 
activity of a population of cells, which range in number from a few 
hundred to thousands. 
2.1.1. Dataset description and data preprocessing 
The dataset used in this study is composed of files from seven 
patients, who were diagnosed with tremor-dominant PD, and who 
all underwent surgery for the implantation of a neurostimulator 
(DBS treatment) at the John Radcliffe Hospital in Oxford, UK. The 
local research ethics committee of the Oxfordshire Health Authority 
approved the recordings and informed consent was obtained from 
each patient. 
For gathering the data, patients took part in an observation 
period of approximately two weeks immediately following implan-
tation, in which recording of data from the electrodes was possible 
during different sessions effectively at this time the electrodes 
were semi-implanted. The purpose of this period was to find the 
most suitable stimulation parameters for tremor suppression. Once 
the observation period was concluded, the electrodes were con-
nected to the implantable pulse generator (IPG), internalized and 
the implantation procedure was complete. 
To the best of our knowledge, nowadays, this observation period 
is often suppressed in the majority of hospitals in order to pre-
vent infections and other possible complications. The patient leaves 
the operating theater with the device - DBS electrodes and IPG 
- fully implanted. As consequence of this is that a dataset of the 
same nature (tremor and non-tremor episodes) to the one used in 
this paper [52] could not be collected. Moreover, considering that 
the neurostimulator - unlike other devices, such as pacemakers or 
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Fig. 1. Preprocessing procedure. 
insulin pumps, does not perform a sensing function, it is not viable 
to obtain the data via telemetry. 
On the other hand, during the surgical implantation, in general 
the patient is continually trembling (medication is suppressed), 
since the best position for the electrode is chosen by measuring 
(and actually looking at) the extent of the tremor in real-time. Sum-
marizing, collecting a dataset with both - tremor and no tremor 
episodes - it is now often a much more difficult task than it used 
to be. This fact is relevant and was taken into consideration in our 
experimentation, as explained below. 
The DBS device employed was a "Medtronic 3387" with four 
electrodes spaced 1.5 mm apart and placed in the STN. In each 
of the patients the electrodes were monitored and a consider-
able collection of data was obtained for each person. The data was 
time stamped and labeled by the surgeons involved, distinguishing 
clearly between tremor and non-tremor episodes. 
Before dealing with the data, some signal manipulations were 
needed. The preprocessing procedure is summarized in Fig. 1 and 
explained below: 
First the signals were down-sampled to the lowest sampling fre-
quency used (250 Hz), since not all the files were originally sampled 
at 250 Hz. 
Secondly a 3-30 Hz Chebyshev Type II passband filter was used 
on the LFP signals. LFP signals contain movement artefacts at 1 -2 Hz 
and this set to 3 Hz the low cut-off frequency. Frequencies above 
the beta-band (>30 Hz) are considered to have little tremor-related 
information [53]. By fixing the upper cut-off frequency at 30 Hz we 
excluded the 50 Hz line noise as well. We chose the Chevyshev type 
II filter because it does not produce any ripple in the pass band and 
thus does not alter the frequency of the signal. 
Third, an amplitude normalization is performed in order to 
reduce amplitude variations across patients, prior comparison 
between them. 
Finally we split the data into 2 s windows with 0% overlapping. 
We opted to use 2 s windows due to the number of samples avail-
able to us and the desired resolution. The window size is based 
on achieving a trade-off between the temporal resolution and the 
number of available samples. That is, the greater is the windows 
size the higher temporal resolution we have at the expense of hav-
ing fewer windows which is counter-productive for the machine 
learning algorithms. The use of 2 s windows provides an adequate 
temporal resolution, since we can study what happens every 1 /2 Hz, 
while we count with a significant number of windows - an aver-
age of 42 per patient. Since the sampling frequency is set to 250 Hz, 
each window consists of 500 samples. 
2.2. Feature extraction 
Once signals had been preprocessed, each window was char-
acterized in terms of a set of features. To extract these features, 
signals could be analyzed in either the time or frequency domain. 
The fast Fourier transform (FFT) is the most used tool for frequency 
domain analysis; however temporal information is lost once the 
transformation is performed. 
If the signal is non-stationary, such as LFP signals, both the 
temporal and frequency components contain relevant information 
about the signal. The short-time Fourier transform (STFT) divides 
the signal into windows and applies the FFT to each of them. 
Although we have a time-frequency representation of the signal, 
it has the restriction that the window size is fixed and resolution is 
thus limited by the selected window. 
A wavelet transform (WT) is a multi-resolution transforma-
tion that uses a variable window size at each level. This allows us 
to get more information about the signal in the time-frequency 
(time-scale) domain. Motivated by this fact WT was used in our 
experimentation. 
In particular, we used the discrete wavelet transform (DWT). 
The resolution was set to 6 levels, which is the maximum possi-
ble decomposition that can be performed considering a sampling 
frequency at 250Hz (number of levels <log2(250/2) - 1). There-
fore each 2 s window is represented by 6 vectors {X¿}S=1>, which 
symbolize the wavelet coefficients at each of the levels. In fact, we 
dealt with the square value of the coefficients, which represents its 
power. For each of these vectors (levels), we calculated 5 features, 
which have proven to be valid in previous studies [38]: 
• Energy: power sum of the coefficients at the i-th level. For a vector 
X,- of length n, the energy is defined as: 
n 
k=\ 
• Average value: represents the mean value of the coefficients 
power at the í - th level. For a vector X,- of length n, the average 
energy is defined as: 
n 
IH = lY.Xi{k) (2) 
• Variance: represents a dispersion measure from the mean energy 
at each level. For a vectorX,- of length n, the variance of the energy 
is defined as: 
n 
Vi = \Y.{Xi{k)->ii)2 (3) 
k=\ 
• First derívate: average value of the first derívate of the energy at 
each level. For a vectorX,- of length n, the average value of the first 
derívate is defined as: 
n 
^ ^ ^ ( X ^ - X ^ - l ) ) (4) 
k=2 
• Entropy: represents the uncertainty value of the energy at each 
level. Let X= {X, p} a discrete space of probability. That is,X={Xit 
X„} is a finite set in which each element has probability p(X,). 
Then, the Shannon entropy s,- is defined as: 
n 
sí = -^P[Xí(/<)]-log2p[Xí(/<)] (5) 
k=\ 
Summarizing; each window of 2 s (500 samples) is character-
ized by 30 values (6 levels x 5 features), which represents a 94% 
reduction of the input space. Mathematically, each sample can be 
represented by a vector as shown below: 
[eíllí0íSíS1,...,e6ll606S6S6] (6) 
3. Proposed system and results 
3.1. Clustering 
As previously discussed in Section 2.1, our studies were based on 
data collected from seven patients; in five cases we had available 
data representing both tremor and no tremor episodes, whilst in 
the remaining two cases only tremor episodes were evident. 
Clustering was only performed with tremor episodes. This can 
be justified based on two main reasons: 
1. We understand that the samples from which we attempt to 
differentiate patients are tremor episodes. We have studied 
non-tremor episodes and these are much more homogeneous 
and similar among patients. From this we postulate that during 
non-tremor episodes there is no significant difference in the sub-
thalamus activity between healthy and Parkinsonian patients. 
2. As consequence of suppressing the observation period after the 
surgical procedure, only tremor episodes are currently available. 
This data can be gathered during the electrode implantation, as 
mentioned in Section 2.1.1. It prevents the possibility of training 
a neural network for a new patient. Only tremor samples would 
be available for this new patient and the system would not be 
able to learn what non-tremor means in this case, impeding the 
automation of the tremor detection. 
The goal at this point is to find out whether it is possible to 
cluster into groups the tremor instances for the set of patients. If 
so, this would indicate the existence of different types of patient, 
or different classes of resting tremor to be more precise. 
The dataset employed was composed of seven patients; and 30, 
84, 96, 82, 53,36 and 114 tremor instances were available for each 
of them respectively. 
3.1.1. Clustering results 
We opted for using the K-means technique since this is one of 
the most used clustering methods in practice. In short, this is an 
unsupervised system. The main goal of clustering algorithms is to 
sort the different instances into groups, so that the degree of asso-
ciation between instances is maximized for the same group. That 
is, the goal is to group instances by proximity. This is performed by 
measuring distances between instances. In particular, the squared 
Euclidean distance is used as metric. 
Table 1 
Clustering results: training and testing patients. 
Cluster 1 
Cluster 2 
Cluster 3 
Cluster 4 
Cluster 5 
Cluster 6 
Total instances 
Type A 
Total instances 
TypeB 
Training patients 
BE 
1 
24 
1 
3 
0 
1 
26 
(96.3%) 
1 
(3.7%) 
MA 
2 
40 
0 
0 
7 
35 
77 
(91.7%) 
7 
(8.3%) 
DC 
20 
45 
0 
5 
18 
8 
73 
(80.2%) 
18 
(19. 8%) 
RB 
0 
1 
1 
1 
79 
0 
1 
(1.2%) 
80 
(98.8%) 
SW 
1 
1 
38 
0 
12 
1 
3 
(5.7%) 
50 
(94.3%) 
Testing patients 
GC 
0 
23 
2 
0 
3 
8 
31 
(86. 
5 
(13. 
1%) 
9%) 
EP 
0 
73 
4 
0 
10 
27 
100 
(87.7%) 
14 
(12.3%) 
In our experimentation, the clustering system was trained in 
order to group instances of five patients into six different clusters. 
The number of clusters were determined following the algorithm 
proposed by Jain and Dubes [54]: 
1. Select an initial partition with K clusters; repeat steps 2 and 3 
until cluster membership stabilizes. 
2. Generate a new partition by assigning each pattern to its closest 
cluster center. 
3. Compute new cluster centers. 
The clustering results are conclusive since the groups obtained 
clearly facilitate the distinguishing of instances into two different 
types of tremor: 
1. Tremor type A, which corresponds to clusters 1, 2 and 6. 
2. Tremor type B, which corresponds to clusters 3 and 5. 
The tremor exhibited by each of the training patients (BE to SW) 
in our study belongs unequivocally to one and only one of these 
tremor types. Table 1 shows the results. Note that cluster 4 is not 
taken into consideration due to the tiny number of instances within 
it. 
Once trained using data from 5 patients only, the system was 
tested with data from the two patients (GC and EP) which was 
not used during training. The results, displayed on the right side 
of Table 1, continue to show a clear tendency to cluster each of the 
patients into one of the groups previously found. In particular, in 
this case both subjects belong to the group or type of tremor A. 
From the results obtained in the clustering task, we can con-
clude that each patient presents one particular type of tremor only. 
But it is interesting to point out that for all the patients, regardless 
of the fact that they are presumed to belong to a particular group, 
there are a very small number of tremor instances that are classi-
fied into the other existing group. This misclassification could be 
caused by physical or neurological causes but the particular reason 
Table 2 
Statistical analysis 
Features 
Energy 
Average 
Variance 
First derivative 
Entropy 
of extracted features. 
Wavelets levels 
Level 1 
Level 2 
Level 3 
Level 4 
Level 5 
Level 6 
Level 1 
Level 2 
Level 3 
Level 4 
Level 5 
Level 6 
Level 1 
Level 2 
Level 3 
Level 4 
Level 5 
Level 6 
Level 1 
Level 2 
Level 3 
Level 4 
Level 5 
Level 6 
Level 1 
Level 2 
Level 3 
Level 4 
Level 5 
Level 6 
Mean 
Tremor type 
A 
2.8794 
2.7769 
1.6990 
0.7595 
0.1270 
0.0023 
5.8866 
5.7777 
5.0119 
4.0653 
2.4918 
0.4059 
5.9025 
5.8478 
3.6547 
1.4299 
0.1045 
3.8229x10-= 
8.9264 
9.2509 
7.6489 
5.1144 
1.6085 
0.0153 
0.1120 
0.1076 
0.0758 
0.0493 
0.0299 
0.0181 
B 
3.5678 
1.5300 
0.4289 
0.1874 
0.0411 
7.4885xl0-4 
6.5612 
4.2117 
2.7299 
2.3625 
1.5018 
0.1612 
7.3970 
3.1928 
0.7607 
0.2845 
0.0360 
1.3967x10-= 
10.4965 
6.1841 
3.1558 
2.4593 
0.5211 
0.0048 
0.1097 
0.1017 
0.0738 
0.0453 
0.0282 
0.0171 
Standard deviation 
Tremor type 
A 
0.9643 
0.9284 
0.8238 
0.5471 
0.1201 
0.0024 
1.0281 
0.9925 
1.0504 
1.1451 
1.0263 
0.3393 
2.1965 
1.8891 
1.9497 
1.2834 
0.1944 
8.5761x10-= 
2.0333 
1.9076 
2.0878 
2.1153 
1.4206 
0.0305 
0.0112 
0.0117 
0.0065 
0.0037 
0.0025 
0.0013 
B 
1.9809 
1.0444 
0.4406 
0.1594 
0.0449 
8.0716xl0-4 
2.0794 
1.3368 
0.9913 
0.9953 
0.9079 
0.1524 
4.1806 
2.5782 
1.3641 
0.6132 
0.1922 
7.7135 xlO-5 
4.1639 
2.7438 
2.1637 
1.7638 
0.9605 
0.0250 
0.0112 
0.0158 
0.0093 
0.0081 
0.0050 
0.0026 
Table 3 
Training of networks 1 and 2 (with cross-validation). 
Table 5 
Testing of Networks 1 and 2 - proposed system. 
Network 1 Network 2 Accuracy 
Used instances 
% Total accuracy 
% Tremor accuracy 
% Non-tremor accuracy 
520 
87 
97 
94 
278 
81.5 
82.5 
82 
Patient ID 
is unknown. Therefore, neuronal activity during tremor episodes 
can be to some extent different for the same patient whilst the 
physical symptom is the same. It may well be however that by fur-
ther studying the exact nature of the tremor in each case this will 
reveal that there are also physical differences between types A and 
B. 
In Table 2 we summarize the average and standard deviation for 
the calculated multi-level features for each group of patients. By 
analyzing these results, we can conclude that the energy, average, 
variance, and first derivative are the features where the differences 
between patients are more significant. We have confirmed this by 
running an algorithm for feature selection. In detail, the Best-First 
and Correlation Feature Selection have been the algorithms used as 
attribute evaluator and search method, respectively. 
Once executed, the selected features are: Energy (levels 1-4), 
Average (levels 3 and 4), Variance (level 3), First Derivative (levels 
2-4). Therefore energy, average, variance and first derivative seem 
to be good distinguishers of subthalamic cell activity. Although, 
these ten values are the most representative, in our experimenta-
tion we finally used the whole set of features since the dimension 
of vectors (i.e., 1 x30) is manageable and slightly improved results 
are obtained. 
3.2. Detection (proposed system) 
Previous works have studied the possibility of demand driven 
stimulation in DBS, as opposed to continual stimulation which is 
the present norm. In this article, due to the knowledge we have 
acquired about tremor types, we find it logical to integrate these 
results with the tremor detection task. Therefore, the proposed sys-
tem combines the tasks of clustering and detection. For this, we 
have designed a detection algorithm in which two different neural 
networks are trained (using tremor and non-tremor instances): one 
per each patient type, A and B, as shown in Table 1. The number of 
instances that are evaluated on each network is shown in Table 3 
in Section 3.2.1, which arguably gives the clearest indication of the 
existence of different tremor types. In the validation phase, each 
patient (tremor instances) is evaluated by the clustering module 
and depending of this result, each sample is assessed in the cor-
responding network. Although mostly each patient belongs to one 
type, all of them have tremor instances in both groups, as shown in 
Table 4 in Section 3.2.2. In Table 5 we computed the degree of accu-
racy in tremor detection for both networks. The weighted average 
value is used since each patient did not have the same number of 
instances in each network. 
Table 4 
Number of instances in networks 1 and 2. 
Patient ID 
Patient BE 
Patient MA 
Patient GC 
Patient RB 
Patient SW 
Patient EP 
Patient DC 
Numbei of instances 
Network 1 type A 
26 
77 
31 
1 
3 
100 
73 
Network 2 type B 
1 
7 
5 
80 
50 
14 
18 
Network 1 
type A 
Network 2 
type B 
% Patient 
weighted average 
Patient BE 
Patient MA 
Patient GC 
Patient RB 
Patient SW 
Patient EP 
Patient DC 
Overall performance 
100 
100 
93.6 
100 
100 
99 
70 
92.0 
100 
85.7 
80 
76.6 
90 
64.3 
88.9 
81.4 
100 
98.8 
91.7 
76.9 
90.6 
94.7 
73.8 
89.5 
The overall system operation scheme (tremor classification type 
and tremor detection), applied for each patient, is shown in Fig. 2. 
3.2.1. Neuronal network design 
We opted to use a neural network given its history of success-
ful application in pattern recognition problems. In our case a Back 
Propagation Multi-Layer Perceptron with one hidden layer with 
16 neurons was chosen. The mathematical statement of the MLP is 
determined by the following equation, from which the correspond-
ing outputs to the inputs provided to the network are calculated: 
:
 vC^düiXi + b) = (p(o/x + b) (7) 
where x is the input vector, a> is the vector of weights, b is the bias 
parameter and <p is the network's activation function. In our case 
we chosen forgone of the two most frequently functions used, the 
sigmoid function 1/(1 +e~x). 
MLP networks are normally used to solve supervised learning 
problems. That is, when the set of inputs and corresponding outputs 
are completely known - in our case, using 30 features per window 
as input, and the presence or absence of tremor as output - the 
system learnt the relationship between inputs and outputs. 
Therefore the feature extraction procedure plays a key role. It is 
only as a result of this that the network can be adequately trained 
to identify the tremor and non-tremor windows. If the features are 
poor, the system would fail in its attempt. 
As shown in Fig. 2, we used two neuronal networks. The input to 
both of the networks, in the training phase, consisted of the whole 
signal (tremor and non-tremor episodes) for each of the five train-
ing patients. More precisely, network 1 is trained with data from 
patients of type A: patients BE, MA and GC, with a total of 520 
instances for all of them. For its part, network 2 is trained with 
patients of type B: patients RB and SW, with a total of 278 instances. 
For the training parameters of both networks we opted for train-
ing with 80%, and testing with the remaining 20% of samples. We 
chose these percentages because the goal at this phase was only 
to train the networks with the validation process at a later stage. 
Note that we did not use 100% of the samples for training in order 
to avoid over-learning. 
The obtained results are summarized in Tables 3 and 4. 
3.2.2. Network validation 
Once the two networks were trained, we validated them. At this 
stage, only tremor episodes were used. This has a twofold justifica-
tion. On one hand, tremor detection is the main goal of our system. 
On the other hand, and due to the abolition of the semi-implanted 
period in much present-day neurostimulator implantation, if the 
system is employed with a new patient, only tremor episodes 
would be available. 
The whole set of patients was tested in the two networks and 
validation was carried out using cross-validation with ten folds. 
t 
Patient's 
tremor 
episodes 
t remor episodestype A 
n e t l 
tremorepisodestype B 
net 2 
Fig. 2. System operation scheme. 
Table 5 shows the accuracy obtained per patient, dividing their 
tremor episodes between the networks, which is based on the clus-
tering results. The degree of overall success is the weighted average. 
All patients exceeded 73% accuracy, achieving 100% accuracy in the 
group of patients used in training (20% of their instances were not 
employed in the training), and 94.7% in the case of the patients not 
utilized during the training. From the obtained results, it seems that 
the system works very well with a high overall accuracy (89.5% of 
overall performance). 
4. Discussion (performance evaluation) 
In order to validate our proposal, we compared the obtained 
results with those obtained when patient data was classified with 
a neural network without tremor distinction. Therefore, no classi-
fication was made distinguishing between types of tremor and the 
clustering of the patients was omitted. 
In this case, the same type of neuronal network was trained 
using the 30 features as previously described: a Multi-Layer Percep-
tron with 80% of samples for training and 20% for testing, and with 
1 hidden layer composed of 16 neurons. The network was trained 
with data from the first five patients (BE to SW), which have tremor 
and non-tremor episodes. In this group of patients, there were two 
different types of tremor episodes, as was shown before, but this 
fact was omitted in order to perform a comparison with our pro-
posed system. That is, we trained only a network with all members 
of this group of 5 patients, instead of training 2 different networks 
(each per type of patient/tremor). 
After training, the network was tested with the tremor episodes 
of each of the 7 patients. 
Comparing the results obtained using this approach (see Table 6) 
with those obtained in the previous section (see Table 5), it can 
be concluded that the performance improves when clustering is 
applied prior to detection. Generally there is an increment in the 
Table 6 
Detection without tremor type clustering. 
Patient ID Accuracy 
Patient BE 
Patient MA 
Patient GC 
Patient RB 
Patient SW 
Patient EP 
Patient DC 
Overall performance 
100 
100 
83.3 
73.17 
92.45 
92.98 
55.20 
83.2 
average accuracy of detection and a greater stability is achieved for 
all the patients. 
5. Conclusions 
In this paper we have studied resting tremor through the LPF 
signals collected from the subthalamus in patients diagnosed with 
tremor dominant idiopathic PD. All the patients present the same 
symptomatology RT in the frequency band between 4 and 6 Hz. We 
aimed to look for the existence of sub-group(s) of patients (tremor 
sub-group). From our experimentation and as a result we showed 
the existence of two subgroups of patients within the group-1 of 
patients according to the Consensus Statement of the Movement 
Disorder Society on Tremor [40]. 
It is acknowledged here that the total number of patients 
involved in this study is relatively small. That said, there were no 
cases which disproved the hypothesis and the results obtained are, 
we feel, strongly supportive. However the next step is to extend 
the study considerably in order to see if all PD cases fall into one or 
other of the two subgroups as categorized or if there appear to be 
any exceptions. 
Clearly the physiological causes of this can be a matter for fur-
ther study and we would not wish to speculate on them here. 
In particular it would be interesting to study, at the neurological 
level, what are the particular causes for this distinction in relation 
to the underlying subthalamic activity. Nevertheless we hope that 
this result may be used as the basis to advance the research into 
types of patients and tremors in Parkinson's disease. Moreover, 
this research advance may help to develop improved and more 
specialized therapies to treat PD. 
Finally, using the obtained results, we propose a novel tremor 
detection mechanism that distinguishes between sub-groups of 
patients and obtains a higher performance (accuracy) than a detec-
tion system that treats all the patients in the same single group. 
Therefore, our proposed system seems an effective tool to assist in 
demand driven deep brain stimulation. 
Appendix A. Clustering 
In order to ensure that two different types of tremor exist in 
our patient dataset, we performed several clustering trials. In each 
experiment, we varied the training set of patients. Our goal here 
was to ascertain if the two groups (type A and B) observed in the 
initial configuration remain irrespective of whether a different set 
of patients is chosen for the training phase. 
In this appendix we present some of the tested configurations. 
Two different types are obtained in all the configurations. More 
Table Al 
Clustering results: extra trial 1. 
Cluster 1 
Cluster 2 
Cluster 3 
Cluster 4 
Cluster 5 
Cluster 6 
Total instances 
Type A 
Total instances 
TypeB 
Training patients 
EP 
38 
23 
3 
42 
8 
0 
103 
(90.4%) 
11 
(9.6%) 
MA 
9 
31 
1 
36 
7 
0 
76 
(90.5%) 
8 
(9.5%) 
DC 
0 
45 
0 
17 
18 
16 
78 
(81.3%) 
18 
(18. 7%) 
RB 
0 
1 
1 
0 
79 
1 
2 
(2.4%) 
80 
(97.6%) 
SW 
3 
0 
37 
1 
12 
0 
4 
(7.5%) 
49 
(92.5%) 
Testing patients 
GC 
1 
7 
2 
23 
3 
0 
31 
(86. 
5 
(13. 
1%) 
9%) 
BE 
22 
2 
1 
2 
0 
3 
29 
(96.7%) 
1 
(3.3%) 
Tremortype A: clusters 1, 2, 4 and 6; tremortype B: clusters 3 and 5. 
Table A2 
Clustering results: extra trial 2. 
Cluster 1 
Cluster 2 
Cluster 3 
Cluster 4 
Cluster 5 
Cluster 6 
Total instances 
Type A 
Total instances 
TypeB 
Training patients 
BE 
1 
22 
2 
0 
4 
1 
29 
(96.7%) 
1 
(3.3%) 
EP 
3 
40 
17 
8 
0 
46 
103 
(90.4%) 
11 
(9.6%) 
DC 
0 
0 
43 
16 
12 
25 
80 
(83.3%) 
16 
(16. 7%) 
RB 
1 
0 
1 
79 
1 
0 
2 
(2.4%) 
80 
(97.6%) 
SW 
38 
1 
0 
12 
2 
0 
3 
(5.7%) 
50 
(94.3%) 
Testing patients 
GC 
2 
1 
7 
3 
1 
22 
31 
(86. 
5 
(13. 
1%) 
9%) 
MA 
1 
9 
22 
7 
0 
45 
76 
(90.5%) 
8 
(9.5%) 
Tremortype A: clusters 2,3, 5 and 6: tremortype B: clusters 1 and 4. 
precisely, in all of them patients RB and SW are from a different 
type than patients BE, EP, MA, DC and GB. 
The obtained results are summarized in Tables A1-A4. The fol-
lowing considerations can be extracted when we analyze in depth 
the data: 
• In Table Al we can observe that patient DC has 16 instances in 
cluster number 6. In this cluster we do not find any instances 
of the remaining patients, so determination of type A or B is, in 
principle, doubtful. We finally classify cluster 6 as type A, because 
the majority of instances of that patient DC are type A. Further-
more, the other two patients that have instances in that cluster 
(patients BE and RB), have more instances within type A. 
• In Table A4 and only observing the training results, it is question-
able whether patient GC belongs to type A or type B, since the 
instances of this patient are mostly in cluster 2, which does not 
have instances from other patients. 
From this, we might conclude that a type C also exists. Never-
theless, if we observe the test results, we can clearly determine 
that cluster 2 belongs to type A - although this decision can-
not be determined during the training phase. On the other hand, 
"this uncertainty" does not appear in the other tables evaluated, 
where all patients clearly show membership, in training and also 
in testing, to one of the existing groups (type A or B) - even this 
patient. 
Note that in this configuration we have not considered clus-
ter 3 since the number of samples belonging to this cluster is 
negligible. 
In all the configurations we can observe that all the patients have 
instances in both types. But adding the total number of instances 
Table A3 
Clustering results: 
Cluster 1 
Cluster 2 
Cluster 3 
Cluster 4 
Cluster 5 
Cluster 6 
Total instances 
Type A 
Total instances 
TypeB 
extra trial 3. 
Training patients 
BE 
1 
22 
0 
3 
0 
4 
27 
(90.0%) 
3 
(10.0%) 
EP 
16 
41 
9 
4 
44 
0 
101 
(88. 
13 
(11. 
6%) 
4%) 
DC 
43 
9 
17 
1 
7 
19 
78 
(81.3%) 
18 
(18. 7%) 
MA 
21 
14 
7 
1 
41 
0 
76 
(90.5%) 
8 
(9.5%) 
SW 
0 
0 
13 
38 
0 
2 
2 
(3.8%) 
51 
(96.2%) 
Testing patients 
GC 
16 
2 
3 
2 
12 
1 
31 
(86. 
5 
(13. 
1%) 
9%) 
RB 
1 
6 
73 
1 
0 
1 
8 
(9.8%) 
74 
(90.2%) 
Tremortype A: clusters 1, 2, 5 and 6: tremortype B: clusters 3 and 4. 
Table A4 
Clustering results: extra trial 4. 
Training patients 
BE MA GC RB SW 
Testing patients 
EP 
24 
8 
0 
4 
68 
10 
100 
(87.7%) 
14 
(12.3%) 
DC 
15 
16 
2 
5 
38 
20 
69 
(73.4%) 
25 
(26.6%) 
Cluster 1 
Cluster 2 
Cluster 3 
Cluster 4 
Cluster 5 
Cluster 6 
Total instances 
Type A 
Total instances 
TypeB 
1 
0 
3 
2 
24 
0 
25 
(92.6%) 
2 
(7.4%) 
36 
0 
0 
1 
40 
7 
76 
(90.5%) 
8 
(9.5%) 
0 
28 
0 
3 
1 
4 
29 
(80.5%) 
7 
(19 5%) 
0 
0 
1 
1 
1 
79 
1 
(1.2%) 
80 
(98.8%) 
1 
0 
0 
38 
1 
13 
2 
(3.8%) 
51 
(96.2%) 
Tremortype A: clusters 1, 2, and 5; tremortype B: clusters 4 and 6. 
it can be seen that every patient clearly belongs to one type. This 
has been the criterion about membership of a patient to type A 
or type B. 
• We have mentioned that although the patients clearly belong to 
one type, they have instances from the other type. If we pay more 
attention to this, it is remarkable that this fact is more noticeable 
for the patients of type A than for type B. That is, patients of type 
A have a membership, although clear, which is less strong than 
patients of type B. 
Summarizing, and after conducting in depth experimentation, 
we conclude that only two types of tremor exist in our patients 
dataset. 
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